MARKET

AVDL

AVDL

Avadel Pharmaceu
NASDAQ
10.38
+0.34
+3.39%
Closed 19:56 07/15 EDT
OPEN
10.09
PREV CLOSE
10.04
HIGH
10.39
LOW
9.98
VOLUME
977.59K
TURNOVER
0
52 WEEK HIGH
17.30
52 WEEK LOW
6.38
MARKET CAP
1.01B
P/E (TTM)
-37.8418
1D
5D
1M
3M
1Y
5Y
1D
Shareholder Activism Intensifies as Avadel Pharmaceuticals Faces Governance Challenges Ahead of Annual Meeting
Reuters · 2d ago
Weekly Report: what happened at AVDL last week (0707-0711)?
Weekly Report · 2d ago
Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor
Seeking Alpha · 07/07 13:30
Weekly Report: what happened at AVDL last week (0630-0704)?
Weekly Report · 07/07 10:01
Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz
Benzinga · 07/01 17:28
Analysts Offer Insights on Healthcare Companies: Skye Bioscience (SKYE), Avadel Pharmaceuticals (AVDL) and Liquidia Technologies (LQDA)
TipRanks · 06/30 13:10
Appeals Court Affirms Favorable FDA Ruling for Avadel in Lumryn Litigation
Dow Jones · 06/30 12:09
Avadel announces appeals court decision upholding FDA approval of LUMRYZ
TipRanks · 06/30 11:25
More
About AVDL
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's product, LUMRYZ, is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the challenges patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA. Its MICROPUMP technology allows for the development of modified-release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified-release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.

Webull offers Avadel Pharmaceuticals PLC (ADR) stock information, including NASDAQ: AVDL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVDL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVDL stock methods without spending real money on the virtual paper trading platform.